Nebulised Heparin in Patients With Severe COVID-19
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 202
Summary
- Conditions
- COVID-19
- Respiratory Failure
- Type
- Interventional
- Phase
- Phase 2Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04545541
- Collaborators
- Not Provided
- Investigators
- Study Chair: Frank MP van Haren, MD, PhD Australian National University